Evidence map›Paper›PMID 34906987›Full record

ReviewBMJ global health2021

Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 West African countries: an interim analysis.

Muhammed Olanrewaju Afolabi, Oghenebrume Wariri, Yauba Saidu, Akaninyene Otu, Semeeh Akinwale Omoleke, Bassey Ebenso, Adekola Adebiyi, Michael Ooko, Bright Opoku Ahinkorah, Edward Kwabena Ameyaw and 6 more

Abstract readReview
In one paragraph

Review in BMJ global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Muhammed Olanrewaju AfolabiDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK Muhammed.Afolabi@lshtm.ac.uk.ORCID 0000-0002-9967-6419
Oghenebrume WaririDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0002-7432-8995
Yauba SaiduClinton Health Access Initiative, Yaounde, Cameroon.
Akaninyene OtuDepartment of Infection and Travel Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.ORCID 0000-0002-6009-2707
Semeeh Akinwale OmolekeField Presence, World Health Organization, Binrin Kebbi, Nigeria.ORCID 0000-0003-0538-9126
Bassey EbensoNuffield Centre for International Health and Development, University of Leeds, Leeds, UK.ORCID 0000-0003-4147-0968
Adekola AdebiyiCollege of Agriculture, Engineering and Environmental Design, Legacy University, Banjul, Gambia.
Michael OokoStatistics & Bioinformatics, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Bright Opoku AhinkorahSchool of Public Health, Faculty of Health, University of Technology Sydney, Liverpool, New South Wales, Australia.ORCID 0000-0001-7415-895X
Edward Kwabena AmeyawSchool of Public Health, Faculty of Health, University of Technology Sydney, Liverpool, New South Wales, Australia.ORCID 0000-0002-6617-237X
Abdul-Aziz SeiduCollege of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, Australia.ORCID 0000-0001-9734-9054
Emmanuel AgogoResolve to Save Lives, (Vital Strategies), Regus 4th Floor, Tower C, Churchgate Plaza, 473 Constitution Avenue, Central Business District, Abuja, Nigeria.
Terna NomhwangeWorld Health Organization, Country Office, Abuja, Nigeria.
Kolawole SalamiWorld Health Organization, Geneve, Switzerland.
Nuredin Ibrahim MohammedDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0002-4067-1103
Sanni YayaSchool of International Development and Global Studies, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0002-4876-6043

Funding

Medical Research Council MR/R010161/1World Health Organization 001
6 · The paper itself

Abstract

The African Union Bureau of Heads of State and Government endorsed the COVID-19 Vaccine Development and Access Strategy to vaccinate at least 60% of each country's population with a safe and efficacious vaccine by 2022, to achieve the population-level immunity needed to bring the pandemic under control. Using publicly available, country-level population estimates and COVID-19 vaccination data, we provide unique insights into the uptake trends of COVID-19 vaccinations in the 15 countries that comprise the Economic Community of West Africa States (ECOWAS). Based on the vaccination rates in the ECOWAS region after three months of commencing COVID-19 vaccinations, we provide a projection of the trajectory and speed of vaccination needed to achieve a COVID-19 vaccination coverage rate of at least 60% of the total ECOWAS population. After three months of the deployment of COVID-19 vaccines across the ECOWAS countries, only 0.27% of the region's total population had been fully vaccinated. If ECOWAS countries follow this trajectory, the sub-region will have less than 1.6% of the total population fully vaccinated after 18 months of vaccine deployment. Our projection shows that to achieve a COVID-19 vaccination coverage of at least 60% of the total population in the ECOWAS sub-region after 9, 12 and 18 months of vaccine deployment; the speed of vaccination must be increased to 10, 7 and 4 times the current trajectory, respectively. West African governments must deploy contextually relevant and culturally acceptable strategies for COVID-19 vaccine procurements, distributions and implementations in order to achieve reasonable coverage and save lives, sooner rather than later.

Indexed as

COVID-19COVID-19 VaccinesAfrica, WesternHumansSARS-CoV-2VaccinationVaccination CoverageVaccine DevelopmentCOVID-19 VaccinesCOVID-19epidemiologypublic healthvaccines

Identifiers

PMID34906987
PMCPMC8718349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.